North Carolina experts discussed CLL, breast cancer, and myeloma treatments and how to expand access to complex cancer care beyond academic centers.
News|Articles|June 5, 2026
5 Notable Oncology FDA Approvals Granted in May
Author(s)Brooke McCormick
Fact checked by: Laura Joszt, MA
FDA decisions in May 2026 included 5 major oncology approvals, including first-in-class therapies for breast cancer, AML, MCL, and NMIBC.
Advertisement
Advertisement
May was an active month for
Related to this article
Biomarker testing, referrals, screening, treatment access, and clinical trial barriers were examined during this recent IVBM.
CDC's Jane Henley, MSPH, explains what's behind falling lung cancer deaths and why 4 in 5 eligible adults still aren't getting screened.
Oncologists say advances in testing and treatment are outpacing staffing, pay, and access.
Upper-extremity synovial sarcoma required more staged surgery, while lower-extremity disease carried more complications and metastases.
In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.
CDC's David A. Siegel, MD, MPH, on rising cancer diagnoses, falling deaths, and where CDC's cancer control resources go next.
The regulatory decisions reflect how advances in biomarkers and molecular medicine are reshaping both diagnosis and treatment.
Advertisement
Advertisement